TecTraum Inc. develops pro2cool®, an investigational medical device that delivers localized cooling to the head and neck as a potential treatment for concussion. Founded when professional athletes joined engineers to address the lack of concussion therapies, the company has studied the system through a multi-center clinical trial involving pediatric hospitals and high school athletes in Ohio and Michigan. The device received FDA Breakthrough Device designation in June 2021 but has not received FDA market authorization.
FDA Breakthrough Device Designation
compliance_program